Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients
Sponsor: Sindh Institute of Urology and Transplantation
Summary
This randomized control trial, which was carried out at Sindh Institute of Urology and Transplantation (SIUT), used a non-probability consecutive sampling technique for six months from January 1, 2025, to June 30, 2025.
Official title: Role of Intravenous Dexmedetomidine in Attenuation of Hemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients: A Prospective Randomised Double-Blind Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-01-01
Completion Date
2025-06-30
Last Updated
2026-04-29
Healthy Volunteers
No
Interventions
Dexmedetomidine
Dexmedetomidine (0.5 mcg/kg) diluted in 20 mLs of normal saline was administered intravenously using a syringe pump over 10 min.
Normal Saline
20 mLs of normal saline was administered intravenously using a syringe pump over 10 min.
Locations (1)
Sindh Institute of Urology and Transplantation
Karachi, Sindh, Pakistan